drug

tocilizumab

1 story · latest Aug 12, 2026

Status: FDA approved Jan 2010 · BLA125276, BLA125472, BLA761354, BLA761420, BLA761498
Brands: Actemra, Actemra Actpen, Avtozma, Roactemra, Tofidence
Code: RO4877533
Trials: 26 registered trials in coverage

Relationships

Developed by Roche

Developed by Celltrion

Developed by Organon and Co

Timeline

Allogene reports Q2 2026 results, cites ALPHA3 futility data and FDA designations for cema-cel

Aug 12Quarterly updateAllogene Therapeutics

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.